Sulfiredoxin as a Potential Therapeutic Target for Advanced and Metastatic Prostate Cancer

The incidence of prostate cancer (PCa) is increasing, and it is currently the second most frequent cause of death by cancer in men. Despite advancements in cancer therapies, new therapeutic approaches are still needed for treatment-refractory advanced metastatic PCa. Cross-species analysis presents...

Descripción completa

Detalles Bibliográficos
Autores principales: Barquilha, Caroline N., Santos, Nilton J., Monção, Caio C. D., Barbosa, Isabela C., Lima, Flávio O., Justulin, Luis A., Pértega-Gomes, Nelma, Felisbino, Sérgio L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201699/
https://www.ncbi.nlm.nih.gov/pubmed/32411320
http://dx.doi.org/10.1155/2020/2148562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201699/
https://www.ncbi.nlm.nih.gov/pubmed/32411320
http://dx.doi.org/10.1155/2020/2148562

Ejemplares similares